Circulating sex hormone levels have been linked to a wide range of cardiovascular risk factors in men, but studies on incident CVD have been inconclusive [1] . Recent data from meta-analyses show an increase in CVD risk with low testosterone in elderly men and no association with estradiol levels [2, 3] . To clarify the role of sex hormones in male CVD risk, we examined the cross-sectional and longitudinal associations between endogenous sex hormones and subclinical atherosclerosis in a population-based cohort of middle-aged and older men.
Circulating sex hormone levels have been linked to a wide range of cardiovascular risk factors in men, but studies on incident CVD have been inconclusive [1] . Recent data from meta-analyses show an increase in CVD risk with low testosterone in elderly men and no association with estradiol levels [2, 3] . To clarify the role of sex hormones in male CVD risk, we examined the cross-sectional and longitudinal associations between endogenous sex hormones and subclinical atherosclerosis in a population-based cohort of middle-aged and older men.
For this analysis we included data from 400 independently living men aged 40 to 80 years, of whom 270 underwent a re-examination after a median follow-up of 8.8 years. Details of the study design and measurements have been reported previously [4] . At baseline, fasting morning blood samples and data on anthropometric parameters, blood pressure, medical history and lifestyle factors were collected. Serum levels of total testosterone (TT), dihydroepiandrosterone sulphate (DHEAS), total estradiol (E2) and sex hormone-binding globulin (SHBG) were measured and free levels of testosterone (FT) and estradiol (FE2) were calculated. We examined three atherosclerotic markers using noninvasive methods. Carotid intima-media thickness (cIMT) and pulse wave velocity (PWV) are markers of early atherosclerotic changes and were measured at baseline and follow-up using a 7.5-MHz linear array transducer (Acuson Aspen) and SphygmoCor device (PWV Medical, Sydney, Australia) respectively. At follow-up, we also evaluated carotid plaque burden as a marker of more advanced atherosclerosis using a 4-level rating scale: 0 = no plaque, 1 = minimal plaque, 2 = moderate plaque and 3 = severe plaque. The Institutional Review Board of the University Medical Center Utrecht approved the study and written informed consent was obtained from all participants. The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology.
We used general linear models to assess the association of sex hormones with 1. cIMT and PWV at baseline; 2. Δ cIMT and PWV (defined as the absolute mean difference of cIMT and PWV divided by the follow-up time (years)) and 3. carotid plaque score at follow-up. Covariates included in the analyses were age, BMI, smoking status, alcohol consumption and antihypertensive and lipid-lowering medication. Analyses for PWV were additionally adjusted for mean arterial pressure and heart rate. Sex hormones were modelled per standard deviation (sd) decrease and tests for effect modification by age were performed using continuous interaction terms. We also analysed sex hormones in quartiles to examine possible non-linear associations. Table 1 shows the baseline characteristics of the study population. The mean (sd) age at entry was 60 (11) years. Men who participated at follow-up were younger, consumed more alcohol, were more often never-smokers and had a lower prevalence of diabetes and cardiovascular disease at baseline. In addition, participants at follow-up had lower blood pressures, lower PWV and cIMT values and higher FT and DHEAS concentrations at baseline (Table 1) . Table 2 shows the results of the cross-sectional and longitudinal analyses for PWV and cIMT. After multivariable adjustment we found no association between endogenous sex hormones and PWV and cIMT, neither for baseline measurements nor for change in PWV and cIMT during follow-up. Also, no association with plaque score at follow-up was observed (data not shown).
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E-mail address: J.S.M.Brand-3@umcutrecht.nl (J.S. Brand). 1 This author takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. However, there was some indication of effect modification by age (P interaction b 0.05). At baseline, low SHBG and testosterone were associated with higher PWV in men aged N70 years only (betas per sd decrease of SHBG and TT were = 0.64 (95% CI: 0.09; 1.20) and 0.48 (95% CI −0.09; 1.06) respectively). Quartile analysis revealed no evidence of nonlinearity and all associations remained unchanged after excluding prevalent CVD cases and men using antihypertensive and lipid-lowering medication. Results were also not materially different after repeating the longitudinal analyses using inverse probability weighting, making selective loss to follow-up an unlikely explanation for our findings.
Results of the present study argue against a major role of endogenous estradiol in male CVD risk. The absence of an association with subclinical atherosclerosis is consistent with data on incident CVD [3] . By contrast, a link with androgens seems to be more plausible. Despite the lack of an overall association between testosterone and subclinical atherosclerosis in this study, which is in agreement with previous findings on cIMT in men of the same age range [5, 6] , low testosterone levels have been associated with atherosclerotic markers in selected populations of elderly men [7] , hypogonadal men [8] and men with low-grade inflammation [9] . In line with this, we found evidence of effect modification by age in crosssectional analyses for PWV, an interaction that has been reported previously for incident CVD [2] . Existing data on DHEAS are also supportive of an association in specific subpopulations [10, 11] , although we could not identify such an association in this study. The few studies on SHBG have yielded inconsistent results, with either a borderline significant association [5] or no association [9] . Our findings for SHBG, however, are in accordance with recent data showing an association between SHBG and cardiovascular events in elderly men [12] .
Altogether, the findings of our and other studies suggest that, if present, the strength of an association is very small in apparently healthy men. Therefore, a more likely explanation for the observed associations in high-risk populations is reverse causation, in which underlying disease processes cause a decrease in testosterone and SHBG levels. Alternatively, the absence of an overall association may be indicative of a threshold effect, with low androgens only putting men at risk below a certain level. This hypothesis is supported by results from testosterone supplementation studies showing improvements in vascular function in hypogonadal men [13] and men with a history of cardiovascular disease [14] , i.e. men having low testosterone levels.
In conclusion, our results do not support an overall association between endogenous sex hormones and subclinical atherosclerosis in middle aged and older men. Large-scale studies focussing on threshold effects are needed to gain more insight into the role of sex hormones in CVD aetiology. andropausal middle-aged men. J Am Coll Cardiol 2005;45:1603-8.
[9] Soisson V, Brailly-Tabard S, Empana JP, et al. Low plasma testosterone and elevated carotid intima-media thickness: importance of low-grade inflammation in elderly men. Atherosclerosis 2012;223:244-9. Table 2 Cross-sectional and longitudinal associations between sex hormone levels and carotid intima media thickness and pulse wave velocity. 
